GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » Insider Ownership

GH Research (FRA:1KA) Insider Ownership : 0.00 % (As of Jun. 08, 2024)


View and export this data going back to 2021. Start your Free Trial

What is GH Research Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, GH Research's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, GH Research's Institutional Ownership is 6.78%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, GH Research's Float Percentage Of Total Shares Outstanding is 28.43%.

GH Research Insider Ownership Historical Data

The historical data trend for GH Research's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research Insider Ownership Chart

GH Research Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Insider Ownership
- - - - -

GH Research Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GH Research Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

GH Research (FRA:1KA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » Insider Ownership
Comparable Companies
IMNM CDMO BMEA MRNS ORTX ALXO ORIC RNA ITOS URGN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
GHRS:USA
Address
28 Baggot Street Lower, Dublin, IRL, D02 NX43
Website
https://www.ghres.com
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

GH Research (FRA:1KA) Headlines

No Headlines